These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21300181)

  • 1. Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).
    Lu M; Freytag SO; Stricker H; Kim JH; Barton K; Movsas B
    Contemp Clin Trials; 2011 May; 32(3):453-60. PubMed ID: 21300181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.
    Freytag SO; Stricker H; Pegg J; Paielli D; Pradhan DG; Peabody J; DePeralta-Venturina M; Xia X; Brown S; Lu M; Kim JH
    Cancer Res; 2003 Nov; 63(21):7497-506. PubMed ID: 14612551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer.
    Freytag SO; Movsas B; Aref I; Stricker H; Peabody J; Pegg J; Zhang Y; Barton KN; Brown SL; Lu M; Savera A; Kim JH
    Mol Ther; 2007 May; 15(5):1016-23. PubMed ID: 17375076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.
    Freytag SO; Stricker H; Lu M; Elshaikh M; Aref I; Pradhan D; Levin K; Kim JH; Peabody J; Siddiqui F; Barton K; Pegg J; Zhang Y; Cheng J; Oja-Tebbe N; Bourgeois R; Gupta N; Lane Z; Rodriguez R; DeWeese T; Movsas B
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):268-76. PubMed ID: 24837889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model.
    Freytag SO; Paielli D; Wing M; Rogulski K; Brown S; Kolozsvary A; Seely J; Barton K; Dragovic A; Kim JH
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):873-85. PubMed ID: 12377341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer.
    Freytag SO; Stricker H; Peabody J; Pegg J; Paielli D; Movsas B; Barton KN; Brown SL; Lu M; Kim JH
    Mol Ther; 2007 Mar; 15(3):636-42. PubMed ID: 17228316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
    van der Linden RR; Haagmans BL; Mongiat-Artus P; van Doornum GJ; Kraaij R; Kadmon D; Aguilar-Cordova E; Osterhaus AD; van der Kwast TH; Bangma CH
    Eur Urol; 2005 Jul; 48(1):153-61. PubMed ID: 15967266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
    Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
    Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
    Westphal M; Ylä-Herttuala S; Martin J; Warnke P; Menei P; Eckland D; Kinley J; Kay R; Ram Z;
    Lancet Oncol; 2013 Aug; 14(9):823-33. PubMed ID: 23850491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
    Herman JR; Adler HL; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme TL; Wheeler TM; Thompson TC; Scardino PT
    Hum Gene Ther; 1999 May; 10(7):1239-49. PubMed ID: 10340555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
    Shalev M; Kadmon D; Teh BS; Butler EB; Aguilar-Cordova E; Thompson TC; Herman JR; Adler HL; Scardino PT; Miles BJ
    J Urol; 2000 Jun; 163(6):1747-50. PubMed ID: 10799174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.
    Freytag SO; Barton KN; Brown SL; Narra V; Zhang Y; Tyson D; Nall C; Lu M; Ajlouni M; Movsas B; Kim JH
    Mol Ther; 2007 Sep; 15(9):1600-6. PubMed ID: 17551507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy.
    Nasu Y; Saika T; Ebara S; Kusaka N; Kaku H; Abarzua F; Manabe D; Thompson TC; Kumon H
    Mol Ther; 2007 Apr; 15(4):834-40. PubMed ID: 17327829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.
    Teh BS; Aguilar-Cordova E; Kernen K; Chou CC; Shalev M; Vlachaki MT; Miles B; Kadmon D; Mai WY; Caillouet J; Davis M; Ayala G; Wheeler T; Brady J; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Butler EB
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):605-13. PubMed ID: 11597799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
    Hall SJ; Mutchnik SE; Chen SH; Woo SL; Thompson TC
    Int J Cancer; 1997 Jan; 70(2):183-7. PubMed ID: 9009158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
    Lee YJ; Lee H; Borrelli MJ
    Cancer Gene Ther; 2002 Mar; 9(3):267-74. PubMed ID: 11896443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
    Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.